Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$64.63 USD
+0.28 (0.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $64.52 -0.11 (-0.17%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
VKTX 64.63 +0.28(0.44%)
Will VKTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VKTX
Viking (VKTX) Rises 25% in a Month: Should You Buy or Wait?
Lilly (LLY) Up 3% on Obesity Drug Cutting Diabetes Risk
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Investment Ideas feature highlights: Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli Lilly
Should You Invest in Novo Nordisk (NVO) Ahead of Q2 Earnings?
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
Other News for VKTX
Biotech Alert: Searches spiking for these stocks today
Director J Singleton Sells 5,700 Shares of Viking Therapeutics Inc (VKTX)
Biotech Alert: Searches spiking for these stocks today
Viking Therapeutics: Leaping Ahead In The Weight-Loss Race
Oppenheimer’s top 32 ideas for August-September